These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33536950)

  • 21. A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients.
    Michalak J; Schultze M; Heidenreich T; Schramm E
    J Consult Clin Psychol; 2015 Oct; 83(5):951-63. PubMed ID: 26371617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
    Thase ME; Rush AJ; Manber R; Kornstein SG; Klein DN; Markowitz JC; Ninan PT; Friedman ES; Dunner DL; Schatzberg AF; Borian FE; Trivedi MH; Keller MB
    J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does childhood emotional abuse moderate the effect of cognitive behavioral analysis system of psychotherapy versus meta-cognitive therapy in depression? A propensity score analysis on an observational study.
    Klein JP; Dale R; Glanert S; Grave U; Surig S; Zurowski B; Borgwardt S; Schweiger U; Fassbinder E; Probst T
    J Affect Disord; 2022 Mar; 300():71-75. PubMed ID: 34952120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining baseline characteristics to disentangle response differences to disorder-specific versus supportive psychotherapy in patients with persistent depressive disorder.
    Serbanescu I; Walter H; Schnell K; Kessler H; Weber B; Drost S; Groß M; Neudeck P; Klein JP; Assmann N; Zobel I; Backenstrass M; Hautzinger M; Meister R; Härter M; Schramm E; Schoepf D
    Behav Res Ther; 2020 Jan; 124():103512. PubMed ID: 31734568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events during a disorder-specific psychotherapy compared to a nonspecific psychotherapy in patients with chronic depression.
    Meister R; Lanio J; Fangmeier T; Härter M; Schramm E; Zobel I; Hautzinger M; Nestoriuc Y; Kriston L
    J Clin Psychol; 2020 Jan; 76(1):7-19. PubMed ID: 31576565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
    Schramm E; Kriston L; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Bausch P; Fangmeier T; Meister R; Berger M; Hautzinger M; Härter M
    JAMA Psychiatry; 2017 Mar; 74(3):233-242. PubMed ID: 28146251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
    Manber R; Arnow B; Blasey C; Vivian D; McCullough JP; Blalock JA; Klein DN; Markowitz JC; Riso LP; Rothbaum B; Rush AJ; Thase ME; Keller MB
    Psychol Med; 2003 May; 33(4):693-702. PubMed ID: 12785471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the Efficacy of CBASP with Two Versions of CBT for Depression in a Routine Care Center: A Randomized Clinical Trial.
    Rief W; Bleichhardt G; Dannehl K; Euteneuer F; Wambach K
    Psychother Psychosom; 2018; 87(3):164-178. PubMed ID: 29649805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP).
    McCullough JP
    J Clin Psychol; 2003 Aug; 59(8):833-46. PubMed ID: 12858425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Childhood Maltreatment on Long-Term Outcomes in Disorder-Specific vs. Nonspecific Psychotherapy for Chronic Depression.
    Bausch P; Fangmeier T; Meister R; Elsaeßer M; Kriston L; Klein JP; Zobel I; Hautzinger M; Härter M; Schramm E
    J Affect Disord; 2020 Jul; 272():152-157. PubMed ID: 32379608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key process issues in Cognitive Behavioral Analysis System of Psychotherapy (CBASP): translation of an evidence-based model into clinical practice and training.
    Vivian D; Salwen J
    Psychotherapy (Chic); 2013 Sep; 50(3):398-403. PubMed ID: 24000859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression.
    Schramm E; Zobel I; Schoepf D; Fangmeier T; Schnell K; Walter H; Drost S; Schmidt P; Brakemeier EL; Berger M; Normann C
    Psychother Psychosom; 2015; 84(4):227-40. PubMed ID: 26022410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Self-Disclosure within DBT, Schema Therapy, and CBASP: Opportunities and Challenges.
    Köhler S; Guhn A; Betzler F; Stiglmayr C; Brakemeier EL; Sterzer P
    Front Psychol; 2017; 8():2073. PubMed ID: 29238317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suicidal behaviors are associated with loneliness and decrease during inpatient CBASP treatment for persistent depressive disorder.
    Wolf J; Padberg F; Nenov-Matt T; Amann BL; Barton BB; Tang J; Glessner G; Brakemeier EL; Jobst A; Musil R; Reinhard MA
    J Psychiatr Res; 2022 Oct; 154():139-144. PubMed ID: 35939998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.
    Jobst A; Sabaß L; Hall D; Brücklmeier B; Buchheim A; Hall J; Sarubin N; Zill P; Falkai P; Brakemeier EL; Padberg F
    J Affect Disord; 2018 Feb; 227():206-213. PubMed ID: 29100154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change in patients' interpersonal impacts as a mediator of the alliance-outcome association in treatment for chronic depression.
    Constantino MJ; Laws HB; Coyne AE; Greenberg RP; Klein DN; Manber R; Rothbaum BO; Arnow BA
    J Consult Clin Psychol; 2016 Dec; 84(12):1135-1144. PubMed ID: 27748609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.
    Trivedi MH; Kocsis JH; Thase ME; Morris DW; Wisniewski SR; Leon AC; Gelenberg AJ; Klein DN; Niederehe G; Schatzberg AF; Ninan PT; Keller MB
    Psychopharmacol Bull; 2008; 41(4):5-33. PubMed ID: 19015627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation into the effects of cognitive behavioral therapy on patients with chronic depression: a small case series.
    Horn GL
    Psychol Res Behav Manag; 2012; 5():123-9. PubMed ID: 23055783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of the cognitive behavioral analysis system of psychotherapy for chronic depression: a randomized controlled trial.
    Wiersma JE; Van Schaik DJ; Hoogendorn AW; Dekker JJ; Van HL; Schoevers RA; Blom MB; Maas K; Smit JH; McCullough JP; Beekman AT; Van Oppen P
    Psychother Psychosom; 2014; 83(5):263-9. PubMed ID: 25116461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.